Pfizer Receivables 2010-2024 | PFE

Pfizer receivables for the quarter ending December 31, 2024 were $11.463B, a 0.89% decline year-over-year.

  • Pfizer receivables for 2024 were $11.463B, a 0.89% decline from 2023.
  • Pfizer receivables for 2023 were $11.566B, a 5.61% increase from 2022.
  • Pfizer receivables for 2022 were $10.952B, a 4.59% decline from 2021.

Pfizer Receivables 2010-2024 | PFE

  • Pfizer receivables for 2024 were $11.463B, a 0.89% decline from 2023.
  • Pfizer receivables for 2023 were $11.566B, a 5.61% increase from 2022.
  • Pfizer receivables for 2022 were $10.952B, a 4.59% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Merck (MRK)$216.5B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B